Description

Dermaheal LL: Peptide-Based Lipolytic for Safe Contouring and Skin Tightening

Dermaheal LL (Lipolytic Level) is a highly effective injectable lipolytic cocktail developed by the South Korean company Caregen. Its uniqueness lies in the synergistic action of classical lipolytic agents (Phosphatidylcholine and L-Carnitine) combined with patented biomimetic peptides. This complex not only selectively targets and destroys adipocytes while accelerating fatty acid metabolism but also provides a powerful tissue-lifting effect. Unlike traditional direct lipolytics, the inclusion of peptides actively stimulates collagen synthesis, preventing skin atony and sagging after fat reduction. This makes it an ideal and highly safe product for treating delicate areas, particularly the face.

Key Clinical Benefits:

Dual Action: Simultaneously reduces localized fat deposits and tightens the skin (a pronounced “liporeduction + lifting” effect).

Safe Lipolysis: The presence of L-Carnitine ensures the rapid, natural utilization of broken-down fats, significantly minimizing the systemic toxic load.

Anti-Cellulite Effect: Effectively smooths the skin’s microrelief, dissolving fibrous bands and eliminating the visual appearance of “orange peel” skin.

Physiological Process: The peptide complex promotes the gentle destruction of fat cells, vastly reducing the risk of severe post-procedural edema and inflammation.

Indications:

Localized fat deposits in the lower third of the face (double chin, jowls, voluminous cheeks).

Body contouring (abdomen, flanks, thighs, buttocks, inner arms, and knees).

Treatment of hydrolipodystrophy (cellulite).

Correction of uneven skin texture following surgical liposuction.

Specifications:

Active Ingredients: Biomimetic Peptides (Decapeptide-4), Phosphatidylcholine, L-Carnitine.

Form: Liquid solution in a vial (5 ml).

Manufacturer: Caregen Co., Ltd. (South Korea).